Investing in Amphastar Pharmaceuticals, Inc. (AMPH)

Valuation methodValue, $Upside, %
Artificial intelligence (AI)61.1662
Intrinsic value (DCF)142.10276
Graham-Dodd Method19.71-48
Graham Formula137.27264

Company description

Amphastar Pharmaceuticals, Inc. (ticker: AMPH) is a publicly traded pharmaceutical company that was founded in 1996 and is headquartered in Rancho Cucamonga, California. The company focuses on developing, manufacturing, and marketing generic and proprietary injectable, inhalation, and intranasal products. They also offer contract manufacturing services for a variety of pharmaceutical products. With a team of scientists and engineers, Amphastar prides itself on its ability to quickly develop and bring new, high-quality products to market. Their products are used by healthcare providers in multiple therapeutic areas, including critical care, hospital care, emergency and urgent care, and respiratory health. In addition, the company operates a subsidiary, AMPH Commerce, that offers a range of blood-related products, such as human and bovine thrombin, to the biopharmaceutical industry. With a strong presence in the US market, Amphastar is continuously expanding its global presence through strategic partnerships and acquisitions. The company has multiple FDA approvals and a strong pipeline of products in development. With a focus on innovation, quality, and growth, Amphastar Pharmaceuticals continues to be a leader in the pharmaceutical industry.